<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03044301</url>
  </required_header>
  <id_info>
    <org_study_id>G-E-CJT-XC-150127</org_study_id>
    <nct_id>NCT03044301</nct_id>
  </id_info>
  <brief_title>Performance Thresholds Evaluation by Wet Injection Quantification and Magnetic Resonance Imaging (MRI) of Subcutaneous and Intramuscular Injections (0,65ml) of Several Configurations of Needle-free Devices (ZENEO®)</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Crossject</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Crossject</source>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the performance of the ZENEO needle free device in
      subcutaneous functioning limits (low performance limit and high performance limit) and for
      intramuscular injections.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 2015</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>depth of the injection by MRI</measure>
    <time_frame>5 minutes after the injection</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">97</enrollment>
  <condition>No Condition</condition>
  <arm_group>
    <arm_group_label>BMI &lt; 25kg/m²</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subcutaneous high ZENEO® injection Intramuscular ZENEO® injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>27.5 &gt; BMI &gt; 25 kg/m²</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Intramuscular ZENEO® injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BMI &gt; 27.5 kg/m²</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Intramuscular ZENEO® injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No special BMI</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subcutaneous low ZENEO® injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Intramuscular ZENEO® injection</intervention_name>
    <description>Sodium Chloride (0.9 %)</description>
    <arm_group_label>BMI &lt; 25kg/m²</arm_group_label>
    <arm_group_label>27.5 &gt; BMI &gt; 25 kg/m²</arm_group_label>
    <arm_group_label>BMI &gt; 27.5 kg/m²</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Subcutaneous high ZENEO® injection</intervention_name>
    <description>Sodium Chloride (0.9 %)</description>
    <arm_group_label>BMI &lt; 25kg/m²</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Subcutaneous low ZENEO® injection</intervention_name>
    <description>Sodium Chloride (0.9 %)</description>
    <arm_group_label>No special BMI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male or female healthy volunteers aged between 18 and 60 years,

          -  affiliated to or covered by the French social security system,

          -  BMI between ≥20 and ≤30 kg/m²

          -  Patients without chronic medical or surgical illness

          -  Patients with normal clinical examination at the screening visit,

          -  Patients with normal blood pressure at the screening visit: systolic BP &lt; 140 mmHg and
             diastolic BP &lt; 90 mmHg, determined with the patient seated and resting for at least 5
             minutes,

          -  Patients within normal range values for the following laboratory tests (appendix I)
             unless the investigator considers an abnormality to be clinically irrelevant (to be
             documented and agreed with the sponsor before inclusion) within 1 month prior to the
             start of the study (only for MRI sub study volunteers),

          -  Absence of cannabis, opiate, cocaine, amphetamine history (only for MRI sub study
             volunteers)

        Exclusion Criteria:

          -  history of drug abuse

          -  history of hypersensitivity (disease or drug)

          -  treatment with platelet inhibiting drugs within one week before inclusion

          -  treatment with anticoagulant within four weeks before inclusion

          -  subject likely to take any medication during the study

          -  contra-indication to MRI: metallic intra-corporeal devices, claustrophobia

          -  prior participation to other interventional clinical research within 3 months

          -  in custody due to administrative or legal decision or under tutelage or being admitted
             in a sanitary or social institution.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 9, 2017</study_first_submitted>
  <study_first_submitted_qc>February 2, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 7, 2017</study_first_posted>
  <last_update_submitted>February 2, 2017</last_update_submitted>
  <last_update_submitted_qc>February 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

